QuidelOrtho Corp (QDEL)

47.22 -0.39 (-0.82%) USD  |  NASDAQ  |  Jan 07, 15:00
More

QuidelOrtho Research and Development Expense (Annual): 246.80M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for QDEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Baxter International Inc 667.00M
Repligen Corp 42.72M
Teleflex Inc 154.35M
Perspective Therapeutics Inc 21.31M
Xtant Medical Holdings Inc 1.336M